Related references
Note: Only part of the references are listed.Iron deposition in periaqueductal gray matter as a potential biomarker for chronic migraine
Clara Dominguez et al.
NEUROLOGY (2019)
Beta-blockers for the prevention of headache in adults, a systematic review and meta-analysis
Jeffrey L. Jackson et al.
PLOS ONE (2019)
Current and emerging evidence-based treatment options in chronic migraine: a narrative review
Elio Clemente Agostoni et al.
JOURNAL OF HEADACHE AND PAIN (2019)
CGRP monoclonal antibody for preventive treatment of chronic migraine: An update of meta-analysis
Lin Han et al.
BRAIN AND BEHAVIOR (2019)
Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adults
Cristina Tassorelli et al.
CEPHALALGIA (2018)
Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition
Jes Olesen
CEPHALALGIA (2018)
Defining the noninferiority margin and analysing noninferiority: An overview
Turki A. Althunian et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Prevalence of cranial autonomic parasympathetic symptoms in chronic migraine: Usefulness of a new scale
Nuria Riesco et al.
CEPHALALGIA (2016)
Phenotypic features of chronic migraine
Osman Ozgur Yalin et al.
JOURNAL OF HEADACHE AND PAIN (2016)
Allodynia and Descending Pain Modulation in Migraine: A Resting State Functional Connectivity Analysis
Todd J. Schwedt et al.
PAIN MEDICINE (2014)
Patterns of Use and Reasons for Discontinuation of Prophylactic Medications for Episodic Migraine and Chronic Migraine: Results From the Second International Burden of Migraine Study (IBMS-II)
Andrew M. Blumenfeld et al.
HEADACHE (2013)
Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine
Eva Cernuda-Morollon et al.
NEUROLOGY (2013)
Regulatory Scientific Advice on Non-Inferiority Drug Trials
Grace Wangge et al.
PLOS ONE (2013)
Chronic Migraine Prevalence, Disability, and Sociodemographic Factors: Results From the American Migraine Prevalence and Prevention Study
Dawn C. Buse et al.
HEADACHE (2012)
Randomized, placebo-controlled trial of propranolol added to topiramate in chronic migraine
S. D. Silberstein et al.
NEUROLOGY (2012)
Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society
S. D. Silberstein et al.
NEUROLOGY (2012)
Mechanism of Chronic Migraine
Sheena K. Aurora et al.
CURRENT PAIN AND HEADACHE REPORTS (2011)
Rates, predictors, and consequences of remission from chronic migraine to episodic migraine
A. Manack et al.
NEUROLOGY (2011)
Global prevalence of chronic migraine: A systematic review
J. L. Natoli et al.
CEPHALALGIA (2010)
OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial
H. C. Diener et al.
CEPHALALGIA (2010)
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
Kenneth F. Schulz et al.
TRIALS (2010)
A DOUBLE-BLIND RANDOMIZED CONTROLLED TRIAL OF LOW DOSES OF PROPRANOLOL, NORTRIPTYLINE, AND THE COMBINATION OF PROPRANOLOL AND NORTRIPTYLINE FOR THE PREVENTIVE TREATMENT OF MIGRAINE
Renan B. Domingues et al.
ARQUIVOS DE NEURO-PSIQUIATRIA (2009)
A Double-Blind Comparison of OnabotulinumtoxinA (BOTOX®) and Topiramate (TOPAMAX®) for the Prophylactic Treatment of Chronic Migraine: A Pilot Study
Ninan T. Mathew et al.
HEADACHE (2009)
Cutaneous allodynia in the migraine population
Richard B. Lipton et al.
ANNALS OF NEUROLOGY (2008)
Evidence of persistent central sensitization in chronic headaches: a multi-method study
Elena Filatova et al.
JOURNAL OF HEADACHE AND PAIN (2008)
Chronic migraine in the population - Burden, diagnosis, and satisfaction with treatment
Marcelo E. Bigal et al.
NEUROLOGY (2008)
Interictal Dysfunction of a Brainstem Descending Modulatory Center in Migraine Patients
Eric A. Moulton et al.
PLOS ONE (2008)
Brainstem dysfunction in chronic migraine as evidenced by neurophysiological and positron emission tomography studies
Sheena K. Aurora et al.
HEADACHE (2007)
Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study
H-C Diener et al.
CEPHALALGIA (2007)
Efficacy and safety of topiramate for the treatment of chronic migraine: A randomized, double-blind, placebo-controlled trial
Stephen D. Silberstein et al.
HEADACHE (2007)
Reporting of noninferiority and equivalence randomized trials - An extension of the CONSORT Statement
G Piaggio et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Cortical inhibition is reduced in chronic and episodic migraine and demonstrates a spectrum of illness
SK Aurora et al.
HEADACHE (2005)
Topiramate in migraine prophylaxis -: Results from a placebo-controlled trial with propranolol as an active control
HC Diener et al.
JOURNAL OF NEUROLOGY (2004)
Share Paper
